
The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at…
IPA also stated that while generics are priced lower than the corresponding brands, it is unfair and unacceptable to link…
On Wednesday, Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin…
Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.
According to the company’s statement, these medications are designed to improve glycemic control in adults with Type 2 Diabetes while…
The approval is only for the 2.5mg tablet. Xarelto is also available in 10mg, 15mg, and 20mg tablets, as well…
Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.
Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials.
Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their purpose is to address…
Trump’s tariff threat: Experts have warned that additional levies will only serve to push up prices in the already costly…
Prior to joining Eris, Ranganathan was Commercial Director, Women’s Health, Metabolics, and International Business at Abbott India Limited.
Traditional CMV treatments, such as ganciclovir and valganciclovir, have notable limitations, including toxicity and bone marrow suppression.
Typhoid is already a disease of concern globally and various endemic countries already have TCV as part of their national…
Bourla’s comments come as drugmakers brace for the possibility of 25% tariff on pharmaceutical imports.
Speaking at the 10th Global Pharmaceutical Quality Summit, organised by the Indian Pharmaceutical Alliance in Mumbai on Thursday, February 27th,…
As of 2024, India has emerged as the world’s largest supplier of generic medicines, with a 9% pharma export growth…
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives.
Earlier this month, the US President said that he intends to impose a “25% or higher” levies on semiconductors and…